Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $3.8 million.

  • Axogen's Change in Inventory rose 18241.84% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 7682.85%. This contributed to the annual value of $10.2 million for FY2024, which is 14697.45% up from last year.
  • Latest data reveals that Axogen reported Change in Inventory of $3.8 million as of Q3 2025, which was up 18241.84% from $1.3 million recorded in Q2 2025.
  • Over the past 5 years, Axogen's Change in Inventory peaked at $4.6 million during Q1 2024, and registered a low of -$1.9 million during Q4 2022.
  • In the last 5 years, Axogen's Change in Inventory had a median value of $1.6 million in 2021 and averaged $1.6 million.
  • Per our database at Business Quant, Axogen's Change in Inventory tumbled by 21250.0% in 2022 and then surged by 38190000.0% in 2024.
  • Quarter analysis of 5 years shows Axogen's Change in Inventory stood at $1.7 million in 2021, then crashed by 212.5% to -$1.9 million in 2022, then skyrocketed by 100.05% to $1000.0 in 2023, then soared by 381900.0% to $3.8 million in 2024, then decreased by 0.34% to $3.8 million in 2025.
  • Its Change in Inventory stands at $3.8 million for Q3 2025, versus $1.3 million for Q2 2025 and $2.3 million for Q1 2025.